Region: Africa & Middle East

The big IP stories you’ll be reading about in 2021

The IAM editorial team identifies what could be this year’s pivotal developments in the global IP market

04 January 2021

The future of Israeli tech is all about telemedicine

While many countries are only just getting clued up about digital healthcare, Israel has long been a trailblazer in this field.

25 November 2020

First Israeli patent for vaccine priority system filed in the UAE

In what marks a historical move for Israel and the United Arab Emirates, an Israeli company has filed a patent at the UAE Industrial Property Office for an AI-based vaccine, signalling that the two countries may work together to release technology to help combat the spread of covid-19.

04 November 2020

Help us to identify the world's leading IP strategists

The research process for the IAM Strategy 300 2021 is now underway and we are inviting nominations as we decide who should be included

28 October 2020

Proposal to waive TRIPS is the latest sign of deepening global IP rifts over covid-19

WHO-backed proposal seeks to suspend key multilateral protections for patents and trade secrets

20 October 2020

Patent sale may have helped seal big Sharp Huawei auto licence

Transfer shows Hon Hai Group is betting on its own ability to license key wireless technology developed by Sharp

20 October 2020

What world class IP management looks like

On top of high-quality, day-to-day performance in areas such as prosecution, litigation and licensing, there are three essential elements an in-house function requires to be part of the elite

12 October 2020

The top 10 takeaways from this year’s Global Innovation Index

The latest edition of the annual WIPO publication reveals that Europe and North America still lead despite rising innovation levels in Asia

09 September 2020

Covid-19 shows promise of AI tools – innovators need IP protection, and fast

Breakthroughs by startups across the APAC region show the IP system is working as intended to incentivise innovation - even in a crowded patent landscape

05 September 2020

It’s not all bad news for biopharma IP monetisation during coronavirus slowdown

Oncology licensing, smaller acquisitions and abundant venture capital provide means of commercialising innovation during M&A decline

13 August 2020

Unlock unlimited access to all IAM content